Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Technology Sector · Fidelity

Biotechnology Portfolio (FBIOX)

Ticker FBIOX · · Holdings as of May 31, 2026

Expense ratio
0.62%$62/yr per $10k
5-yr return
+3.5%annualized
1-yr return
+36.4%as of Apr 2026
Net assets
$5.3Ball share classes
Holdings
215

Bottom line

Is FBIOX a good fund? The bottom line

FBIOX is a managed technology sector mutual fund from Fidelity.

Annual fees run 0.62% — about $62 a year on every $10,000 invested, cheaper than 67% of technology sector funds we track.

It returned +36.4% over one year, +3.5% a year over five years, +6.9% a year over ten (as of Apr 30, 2026, per its prospectus).

With $5.3 billion in net assets and 215 holdings, its largest position is Krystal Biotech Inc (10.6%) and the top 10 make up 46.4% of the portfolio.

What stands out

  • Broadly diversified (215 holdings)

Updated Nov 19, 2026

What FBIOX invests in

Biotechnology Portfolio seeks capital appreciation.

Normally investing at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes , and companies that benefit significantly from scientific and technological advances in biotechnology. These companies may include, for example, companies engaged in the research, development, manufacturing, or marketing of products based in whole or in part on genetic analysis and genetic engineering. For purposes of the fund's policy to normally invest at least 80% of its assets in securities of companies principally engaged in the business activity or activities identified for the fund, Fidelity may consider a company to be principally engaged in the designated business activity or activities based on: (i) the level of a company's assets, income, sales, or profits that are…

From the fund's prospectus (filed Apr 24, 2026).

FBIOX performance

Fund calendar-year total returns, 2016–2025 2016: −23.7%; 2017: +27.9%; 2018: −10.7%; 2019: +36.0%; 2020: +38.3%; 2021: −12.4%; 2022: −15.9%; 2023: +10.1%; 2024: +7.3%; 2025: +36.4% −24% 2016 +28% 2017 −11% 2018 +36% 2019 +38% 2020 −12% 2021 −16% 2022 +10% 2023 +7% 2024 +36% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
FBIOX+36.4%+3.5%+6.9%
Technology Sector median+24.0%+10.0%+16.7%

Source: Fund prospectus, as of Apr 30, 2026

Full FBIOX performance history →

What FBIOX costs

On a $10,000 investment, FBIOX's 0.62% expense ratio costs about $62 a year. The prospectus estimates $774 in total costs over 10 years (assuming 5% annual returns). The median technology sector fund charges 0.75%.

See the full FBIOX fee table →

FBIOX top 10 holdings

#Holding% of fund
1Krystal Biotech Inc10.58%
2Abbvie Inc9.22%
3Amgen Inc6.53%
4Gilead Sciences Inc4.82%
5Fidelity Revere Street Trust3.35%
6Alnylam Pharmaceuticals Inc2.93%
7Praxis Precision Medicines Inc.2.47%
8Insmed Inc2.25%
9Argenx Se2.25%
10Ascendis Pharma A/s2.04%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 46.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to FBIOX

More funds like FBIOX →

FBIOX FAQ

What is the expense ratio of FBIOX?
FBIOX's expense ratio is 0.62%, which works out to about $62 a year for every $10,000 invested. The prospectus estimates total costs of $774 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is FBIOX a good investment?
It depends on your goals, but the data points to: broadly diversified (215 holdings). This is general information, not personalized advice.
What does FBIOX hold?
FBIOX's largest holdings are Krystal Biotech Inc (10.6%), Abbvie Inc (9.2%), Amgen Inc (6.5%), Gilead Sciences Inc (4.8%), Fidelity Revere Street Trust (3.4%). It holds 215 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is FBIOX's 5-year return?
FBIOX returned +3.5% a year over the five years ending Apr 30, 2026, and +6.9% a year over ten years. Past performance does not guarantee future results.
Who manages FBIOX?
FBIOX is offered by Fidelity through Fidelity Select Portfolios.